Browsing publications by Professor Nicola Curtin

Newcastle AuthorsTitleYear
Dr Miranda Patterson
Professor Nicola Curtin
Microsatellite instability induced mutations in DNA repair genes Ctip and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors in myeloid malignancies2013
Fiona Middleton
Dr Tao Chen
Professor Nicola Curtin
Chemosensitisation By, and Single Agent Activity of, ATR Inhibitor VE-821 in Human Breast Cancer Cells2012
Dr Joanne Munck
Michael Batey
Dr Yan Zhao
Dr Celine Cano
Dr Michele Tavecchio
et al.		Chemosensitisation of cancer cells by KU-0060648; a dual inhibitor of DNA-PK and PI-3K2012
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Dr Ahmed Elattar
Dr San Soo Hoo
Bisha Uzir
et al.		Clinicopathological features of homologous recombination deficient epithelial ovarian cancers: Sensitivity to PARP inhibitors, platinum and survival2012
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Dr Ahmed Elattar
Dr San Soo Hoo
Bisha Uzir
et al.		Clinicopathological features of homologous recombination deficient epithelial ovarian cancers: Sensitivity to PARP inhibitors, platinum and survival2012
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Dr Ahmed Elattar
Dr San Soo Hoo
Bisha Uzir
et al.		Clinicopathological Features of Homologous Recombination-Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival2012
Dr Aiste Cerbinskaite
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Professor Nicola Curtin
Professor Richard Edmondson
et al.		Defective homologous recombination in human cancers2012
Professor Nicola Curtin
DNA repair dysregulation from cancer driver to therapeutic target2012
Liam Cornell
Dr Joanne Munck
Professor Nicola Curtin
Dr Helen Reeves
DNA-PK or ATM inhibition inhibits non-homologous end joining and enhances chemo- and radio sensitivity in hepatocellular cancer cell lines2012
Dr Britta Vormoor
Sarah Wilkinson
Fiona Harvey
Professor Ruth Plummer
Professor Nicola Curtin
et al.		Ewing's Sarcoma Cells Can Be Sensitized to Temozolomide and to a Lesser Extent to Radiotherapy by Co-treatment with a PARP-inhibitor (AG014699)2012
12345678910111213141516171819